Middle East & Africa Bioprocessing Market Forecast to 2031

At 11.0% CAGR, Middle East & Africa Bioprocessing Market is Speculated to be Worth US$ 725.54 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa bioprocessing market was valued at US$ 314.37 million in 2023 and is expected to reach US$ 725.54 million by 2031, registering a CAGR of 11.0% from 2023 to 2031. Increasing prevalences of chronic diseases and proliferating demand for personalized medicine are among the critical factors attributed to drive the Middle East & Africa bioprocessing market growth.

The sedentary life of older people has boosted the prevalence of lifestyle disorders, such as obesity and diabetes. Inherited genes can also express these conditions along with other health concerns such as cardiovascular disease (CVDs), Alzheimer’s disease, and depression. According to WHO, in 2020, there were more adults over 60 than children under five. The percentage of the global population over 60 will almost double from 12% to 22% between 2015 and 2050. Numerous chronic disorders, such as dementia, osteoarthritis, cancer, stroke, and cardiovascular disease, are known to be associated with aging. CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction caused because of hectic lifestyles, are among the significant causes of mortality across the world. As per the World Heart Foundation, mortality caused due to CVD has surged by 60% over the past 30 years (1990-2020). 20.5 million deaths were recorded in 2021 due to CVDs. Diabetes is one of the life-threatening chronic diseases with no functional cure. Diabetes of all types can cause various complications in different body parts, thereby increasing the overall risk of death. According to the International Diabetes Federation. Additionally, 425 million people had diabetes in 2017, and the number is anticipated to reach 629 million by 2045 worldwide, which is an increase of about 35%. As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, 19.3 million cancer cases were reported across the world. Similarly, as per the World Health Organization data published in February 2022, ~10 million people across the world have succumbed to death due to cancer. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment.

The recognition of biosimilars as efficient and safe by specialists, patients, primary care clinicians, and other healthcare professionals is propelling its demand. Biosimilars have been proven to improve the quality of life for millions of patients. They are impactful and cost-effective options for treating many diseases, including chronic skin conditions (such as psoriasis and atopic dermatitis), bowel diseases (such as Crohn’s disease, irritable bowel syndrome, and colitis), diabetes, autoimmune disease, cancer, kidney conditions, and arthritis. Biosimilar developers are adopting advanced bioprocessing technologies to achieve lower manufacturing costs, which is an important factor in determining the final consumer prices. Nearly all biosimilar developers are using modern, cutting-edge bioprocessing techniques. Therefore, with the growing prevalence of chronic diseases, the demand for biosimilars to treat life-threatening illnesses is spurring, thereby propelling the demand for bioprocessing.

On the contrary, stringent regulatory policies and limitations associated with bioprocessing hamper the growth of Middle East & Africa bioprocessing market.

Based on product, the Middle East & Africa bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held 66.8% market share in 2023, amassing US$ 209.85 million. It is projected to garner US$ 501.83 million by 2031 to register 11.5% CAGR during 2023-2031. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Middle East & Africa bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held 81.9% share of Middle East & Africa bioprocessing market in 2023, amassing US$ 257.48 million. It is anticipated to garner US$ 611.51 million by 2031 to expand at 11.4% CAGR during 2023-2031.

By process, the Middle East & Africa bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess aids segment held 60.8% share of Middle East & Africa bioprocessing market in 2023, amassing US$ 191.27 million. It is projected to garner US$ 451.27 million by 2031 to expand at 11.3% CAGR from 2023 to 2031.

Based on application, the Middle East & Africa bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held 37.9% share of Middle East & Africa bioprocessing market in 2023, amassing US$ 119.29 million. It is predicted to garner US$ 257.36 million by 2031 to expand at 10.1% CAGR between 2023 and 2031.

In terms of end user, the Middle East & Africa bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies held 52.9% share of Middle East & Africa bioprocessing market in 2023, amassing US$ 166.31 million. It is estimated to garner US$ 389.57 million by 2031 to expand at 11.2% CAGR during 2023-2031.

By country, the Middle East & Africa bioprocessing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 40.0% share of Middle East & Africa bioprocessing market in 2023. It was assessed at US$ 125.88 million in 2023 and is likely to hit US$ 299.79 million by 2031, registering a CAGR of 11.5% during 2023-2031.

Key players operating in the Middle East & Africa bioprocessing market are Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc, and Cytiva US LLC, among others.

In November 2023, 3M Co revealed the newest model in its line of chromatographic clarifiers. For the purpose of separating monoclonal antibodies, recombinant proteins, and biologics, Harvest RC Chromatographic Clarifier, BT500 is a 500 mL chromatographic clarifier designed for single use. Based on 5-8% packed cell volume (PCV) culture, the business claims that the BT500 can generate predictive yield samples in 10 minutes. Customers seeking to optimize productivity in the laboratory can now better meet the rapidly increasing demands of the industry with the addition of 3M Harvest RC Chromatographic Clarifier, BT500, to their product line.

In February 2024, The Eppendorf Group is growing by establishing a new site in South Africa. A sophisticated pipette calibration laboratory with a service workshop and a customer experience center featuring Eppendorf equipment are among the amenities offered by the branch office, which is situated in Johannesburg’s Waterfall City economic center. This location provides top-notch laboratory services, such as instrument maintenance and customer training.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioprocessing Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market – Middle East & Africa Analysis
5.1 Middle East & Africa Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Bioprocessing Market Analysis – by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
6.2.2.1.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
6.2.2.1.2 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
7. Middle East & Africa Bioprocessing Market Analysis – by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Bioprocessing Market Analysis – by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Bioprocessing Market Analysis – by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Bioprocessing Market Analysis – by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Bioprocessing Market – Country Analysis
11.1 Middle East & Africa
11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
11.1.1.3 South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User
11.1.1.5 United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.7.1 Overview
11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Research Team
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Bioprocessing Market Segmentation
Table 2. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Instruments
Table 3. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Bioreactors
Table 4. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Chromatography Systems
Table 5. Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – By Consumables & Accessories
Table 6. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 7. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 8. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 9. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 10. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 11. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 12. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 13. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 14. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 15. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 16. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 17. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 18. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 19. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 20. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 21. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 22. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 23. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 24. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 25. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 26. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 27. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 28. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 29. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 30. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 31. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 32. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 33. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 34. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Instruments
Table 35. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Bioreactors
Table 36. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Chromatography Systems
Table 37. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Consumables & Accessories
Table 38. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Scale of Operation
Table 39. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Process
Table 40. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 41. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 43. Recent Organic Growth Strategies in the Bioprocessing Market
Table 44. Glossary of Terms, Bioprocessing Market

LIST OF FIGURES

Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) – by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) – by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) – by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) – by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) – by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Growth Strategies in the Bioprocessing Market